Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,496.00    28.00 (0.63%)
Bid:
4,494.00
Ask:
4,504.00
Spread: 10.00 (0.223%)
Market Cap: £2.10b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Muse Developments appointed preferred bidder

7 May 2013 09:00

RNS Number : 0362E
Morgan Sindall Group PLC
07 May 2013
 



7 May 2013

MORGAN SINDALL GROUP PLC

Muse Developments appointed preferred bidder for redevelopment of St Nicholas House,

former Aberdeen City Council HQ

Morgan Sindall Group plc announces that Muse Developments, its Urban Regeneration division, in joint venture with Aviva Investors, has been appointed as preferred bidder to work with Aberdeen City Council on the redevelopment of the St Nicholas House site in Aberdeen. The project will be fully funded by Aviva Investors, and has an overall value in excess of £100m.

Muse Developments proposes to develop a vibrant new mixed-use quarter for the city on the brownfield site which previously housed the local authority's corporate headquarters. The proposal is for a development which will house offices, a boutique hotel, cafés, restaurants and retail space, as well as creating a significant amount of public space including a small civic square and pedestrianising Broad Street. Provost Skene's House is also included in the proposals.

The Council will lease the development from Muse and receive a proportion of the rental profits for 35 years, after which the site and development will transfer into council ownership.

A public consultation lasting 12 weeks will be carried out before any planning application is submitted. The site will be developed in a single phase and Muse aims for completion during 2016.

John Morgan, Chief Executive of Morgan Sindall Group, commented: "Muse Developments is delighted with the opportunity of working on this scheme. We have a strong track record in similar joint venture regeneration projects and are confident that we will deliver a successful living and working destination. We are excited to be working with Aberdeen City Council and look forward to bringing innovation and long-term value for the people of Aberdeen."

ENDS

Editor's notes: 

Morgan Sindall Group plc

Morgan Sindall Group plc is a leading UK construction and regeneration group with a turnover of £2 billion, employing around 6,500 employees and operating in the public and commercial sectors. It operates through five divisions of construction and infrastructure, fit out, affordable housing, urban regeneration and investments.

Muse Developments

Muse Developments is one of the country's leading names in commercial development and urban regeneration. A national developer - with regional operations in Manchester, London, Leeds and Glasgow. It delivers complex mixed-use schemes - with the accent on quality and sustainability - and creates vibrant new places in towns and cities. Founded on the extensive experience of its management and delivery teams, Muse is driven by a desire to bring a fresh and innovative approach to property development. Muse is part of Morgan Sindall Group plc, a leading UK construction and regeneration group with revenue of over £2 billion and which operates through five divisions of construction and infrastructure, affordable housing, fit out, urban regeneration and investments.

 

ENQUIRIES:

 

Morgan Sindall Group plc Tel: 020 7307 9200

John Morgan, Chief Executive

Steve Crummett, Finance Director

 

 

 

Brunswick Tel: 0207 404 5959

Nina Coad

Alison Kay

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRANKNDBABKDAPK
Date   Source Headline
2nd Jun 202511:14 amRNSCompany Secretary Change
8th May 20258:36 amRNSAdditional Listing
7th May 20252:30 pmRNSHolding(s) in Company
1st May 202512:42 pmRNSResult of AGM
1st May 20259:30 amRNSTotal Voting Rights
1st May 20257:00 amRNSTrading Update
22nd Apr 20252:00 pmRNSCompany Secretary Change
22nd Apr 202510:11 amRNSBlock listing Interim Review
22nd Apr 20258:43 amRNSHolding(s) in Company
1st Apr 20259:38 amRNSTotal Voting Rights
27th Mar 20259:53 amRNSDirector/PDMR Shareholding
25th Mar 20251:50 pmRNSAdditional Listing
25th Mar 20257:00 amRNSTrading Update
24th Mar 20254:32 pmRNSHolding(s) in Company
20th Mar 20252:08 pmRNSAnnual Financial Report
14th Mar 202511:14 amRNSDirector/PDMR Shareholding
7th Mar 20251:33 pmRNSDirector/PDMR Shareholding
7th Mar 20251:26 pmRNSDirector/PDMR Shareholding
6th Mar 20254:42 pmRNSDirector/PDMR Shareholding
6th Mar 20254:38 pmRNSDirector/PDMR Shareholding
5th Mar 20258:56 amRNSDirector/PDMR Shareholding
3rd Mar 20259:41 amRNSTotal Voting Rights
26th Feb 20257:00 amRNSResults for the Full Year Ended 31 December 2024
19th Feb 20253:20 pmRNSHolding(s) in Company
11th Feb 202512:00 pmRNSAppointment of Joint Corporate Broker
7th Feb 20252:37 pmRNSHolding(s) in Company
3rd Feb 202510:10 amRNSTotal Voting Rights
16th Jan 20257:07 amRNSDirector Declaration
16th Jan 20257:00 amRNSNotice of Full Year Results
15th Jan 20257:00 amRNSDirectorate Change
2nd Jan 202511:56 amRNSTotal Voting Rights
20th Dec 20243:54 pmRNSDirector/PDMR Shareholding
2nd Dec 202410:02 amRNSTotal Voting Rights
6th Nov 20241:18 pmRNSHolding(s) in Company
1st Nov 202410:33 amRNSTotal Voting Rights
30th Oct 20244:17 pmRNSDirector/PDMR Shareholding
28th Oct 20249:24 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update and Outlook for 2024
21st Oct 20249:27 amRNSBlock listing Interim Review
15th Oct 202412:22 pmRNSAdditional Listing
1st Oct 202412:09 pmRNSTotal Voting Rights
27th Sep 20242:46 pmRNSDirector/PDMR Shareholding
10th Sep 202411:44 amRNSAdditional Listing
2nd Sep 202410:45 amRNSTotal Voting Rights
30th Aug 202410:35 amRNSHolding(s) in Company
30th Aug 20249:29 amRNSDirector/PDMR Shareholding
23rd Aug 20242:48 pmRNSDirector/PDMR Shareholding
12th Aug 20249:52 amRNSHolding(s) in Company
9th Aug 20244:50 pmRNSHolding(s) in Company
8th Aug 20247:00 amRNSRESULTS FOR THE HALF YEAR (HY) ENDED 30 JUNE 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.